A CME Dinner Series Program

Comparing & Contrasting Basal Insulin Strategies

In Type 1 and Type 2 Diabetes

CONTINUING MEDICAL EDUCATION

For MDs, CDEs, RNs, and ALL YOU SAVVY HEALTHCARE PROS!

 

Dinner & CME with TCOYD

For Savvy Healthcare Professionals

WHY YOU NEED DINNER & CME WITH TCOYD

Savvy healthcare professionals who attend Comparing & Contrasting Basal Insulin Strategies will…

  • LEARN from the nations LEADING experts in diabetes treatment
  • Earn 1.50 CME CREDITS
  • Enjoy a delicious BUFFET DINNER
  • Receive a DOWNLOADABLE slide deck of the speaker presentation
  • Most importantly, help THEIR PATIENTS reach their treatment goals

 

WHAT YOU CAN EXPECT TO LEARN 

Program Overview:

This program aims to educate health care providers in regards to the new basal insulins that have recently been approved by the FDA. The program will focus on the clinically important properties of these new insulins, familiarizing health care providers with their pharmacokinetics, pharmacodynamics, how they should be initiated, titrated and exchanged for other insulins in appropriate patients who may benefit from these newer formulations.

…after attending this CME dinner program you will be able to:

  • Compare & contrast the etiology, natural history & basal insulin needs in type 1 and type 2 diabetes
  • Explain the different approaches to initiation & titration of basal insulin in type 1 vs. type 2 diabetes
  • Describe the pharmacokinetics and pharmacodynamics of the new basal insulin preparations, how these differ from traditional basal insulins, and potential benefits from using the new basal insulin preparations
  • Develop a rationale of when & how to use new basal insulin
  • Understand how to assess basal insulin doses with the use of overnight and daytime fasting and interpretation of CGM data for type 1s.
  • Understand how to monitor basal insulin adjustment with HGM for type 2s

PRESENTED BY TCOYD’s FOUNDER & DIRECTOR

Meet TCOYD’s Founder & Director

Dr. Steven V. Edelman is a Clinical Professor of Medicine at UCSD School of Medicine, the Director of the Diabetes Care Clinic at the VA Medical Center in San Diego and a type 1 since the age of 15. He’s dedicated his medical career to bringing diabetes education and cutting-edge management strategies directly to the people who need it most, people who have diabetes and the medical professionals who treat them.

“TCOYD always provides great diabetes education for healthcare providers. Informative & entertaining, what more could you ask for?”

Past CME Dinner Participant

…additional speakers include a mix of rotating key opinion leaders who bring exciting & engaging education to seeking professionals.

  • William Polonsky, PhD, CDE – President, Behavioral Diabetes Institute; Associate Clinical Professor, Department of Psychiatry, University of California San Diego
  • Ian Blumer, MD, FRCPC – Charles H. Best Diabetes Centre, University of Toronto
  • James R. Gavin III, MD, PhD – Clinical Professor of Medicine, Emory University School of Medicine
  • Maury Gloster, MD – Founder of the Sutter Diabetes Care Center; Medical Consultant, Medical Board of California, Sacramento, CA
  • Tricia Santos Cavaiola, MD – University of California, San Diego School of Medicine
  • Juan P. Frias, MD – President, National Research Institute; Clinical Faculty, Department of Medicine, University of California, San Diego
  • Robert R. Henry, MD – Director, Center for Metabolic Research; Chief, Section of Diabetes, Endocrinology and Metabolism, San Diego VA Healthcare System; Professor of Medicine, University of California, San Diego
  • Jeremy Pettus, MD – Assistant Professor, UC San Diego, School of Medicine, Division of Endocrinology, Co-Director, Type 1 Track, TCOYD
  • J. Ross Tanner, DO, FACP – Internal Medicine and Clinical Lipidology, Diabetes and Lipid Clinic of Alaska
  • Melissa Magwire, RN, CDE – Endocrine Clinic Supervisor; Shawnee Mission Endocrinology and Diabetes, Kansas
  • John E. Anderson, MD – Past President, The First Clinic

CLICK ON YOUR CITY BELOW FOR MORE DETAILS & REGISTRATION 

April 26, 2018

Comparing and Contrasting Basal Insulin Strategies in Type 1 and Type 2 Diabetes

Spokane, WA

May 17, 2018

Comparing and Contrasting Basal Insulin Strategies in Type 1 and Type 2 Diabetes

Nashville, TN

July 11, 2018

Comparing and Contrasting Basal Insulin Strategies in Type 1 and Type 2 Diabetes

San Diego, CA

August 2, 2018

Comparing and Contrasting Basal Insulin Strategies in Type 1 and Type 2 Diabetes

Sacramento, CA

August 8, 2018

Comparing and Contrasting Basal Insulin Strategies in Type 1 and Type 2 Diabetes

Santa Clara, CA

September 26, 2018

Comparing and Contrasting Basal Insulin Strategies in Type 1 and Type 2 Diabetes

Albany, NY

October 11, 2018

Comparing and Contrasting Basal Insulin Strategies in Type 1 and Type 2 Diabetes

Seattle, WA

ADDITIONAL CME CONFERENCE OFFERINGS

Making the Connection Between Patients & Providers: A Comprehensive Overview of the Modern Treatment Strategies for People with Type 1 & Type 2 Diabetes

CLICK A CITY FOR MORE INFOREGISTRATION

Feb. 3, 2018

Anchorage, AK

William A. Egan Civic & Convention Center

March 3, 2018

Sacramento, CA

Sacramento Convention Center Complex

March 17, 2018

Monterey, CA

Monterey Conference Center

April 7, 2018

Novi, MI

Suburban Collective Showplace

May 5, 2018

Honolulu, HI

Hawaii Convention Center

June 2, 2018

Spokane, WA

Spokane Convention Center

Sept. 8, 2018

Nashville, TN

Music City Center

Nov. 17, 2018

San Diego, CA

San Diego Convention Center

ACCREDITATION INFORMATION

Learning Objectives

At course completion, participants should be able to:

1. Compare and contrast the etiology, natural history and basal insulin needs in type 1 and type 2 diabetes.2. Explain the different approaches to initiation and titration of basal insulin in type 1 versus type 2 diabetes.
3. Describe the pharmacokinetics and pharmacodynamics of the new basal insulin preparations, how these differ from traditional basal insulin, and potential benefits from using the new basal insulin preparations.4. Develop a rationale when and how to use new basal insulin preparations in type 1 vs. type 2 diabetes.
5. For individuals with type 1 diabetes, understand how to assess basal insulin doses with the use of overnight and daytime fasting and interpretation of CGM data.6. For individuals with type 2 diabetes, understand how to monitor basal insulin adjustment with home glucose monitoring.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Uni­versity of California, San Diego School of Medicine and Taking Control of Your Diabetes. The University of California, San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Cate­gory 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of re-licensure, the Califor­nia Board of Registered Nursing accepts AMA PRA Category 1 credits™ (report up to1.5 hours of credit and list “CME Category 1” as the provider number).

Physician Assistants: The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Phy­sician assistants may receive a maximum of 1.5 hours of Category 1 credit for completing this program.

Pharmacists: The California Board of Pharmacy accepts as continuing education for pharmacist’s coursework which meets the standard of relevance to pharmacy practice and is accepted as continuing education by the Medical Board of California.

Certified Diabetes Educators: The University of California, San Diego is accredited by the ACCME, which is on the NCBDE list of approved providers.

Cultural and Linguistic Competency

This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources can be found on the UC San Diego CME website.

GET YOUR CME CREDITS!

Did you recently attend the Making the Connection program?

Click to claim your much deserved CME credits! Hope you enjoyed the conference!

Acknowledgement of Commercial Support

This activity is supported by the following organization:

Sanofi US

LATEST TYPE 1 POSTS

LATEST TYPE 2 POSTS

990 Highland Drive, Suite 312
Solana Beach, CA 92075
800.998.2693